# Sanofi's Biotech Investments: 50 Startups in Its Portfolio (2026) > The 50 Biotech startups Sanofi has backed, by stage: $6.1B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/sanofi-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series B 18 - [Fulcrum Therapeutics](https://millionrounds.com/company/fulcrum-therapeutics) - [Expedition Therapeutics](https://millionrounds.com/company/expedition-therapeutics) - [T-Therapeutics](https://millionrounds.com/company/t-therapeutics) - [Mirador Therapeutics](https://millionrounds.com/company/mirador-therapeutics) - [Matchpoint Therapeutics](https://millionrounds.com/company/matchpoint-therapeutics) - [Nura Bio](https://millionrounds.com/company/nura-bio) - [Vigil Neuroscience](https://millionrounds.com/company/vigil-neuroscience) - [NodThera](https://millionrounds.com/company/nodthera) - [Atalanta Therapeutics](https://millionrounds.com/company/atalanta-therapeutics) - [QurAlis](https://millionrounds.com/company/quralis) - [QuantX Biosciences](https://millionrounds.com/company/quantx-biosciences) - [NextPoint Therapeutics](https://millionrounds.com/company/nextpoint-therapeutics) - [ROME Therapeutics](https://millionrounds.com/company/rome-therapeutics) - [Lumena Pharmaceuticals](https://millionrounds.com/company/lumena-pharmaceuticals) - [*GB* Granite Bio](https://millionrounds.com/company/granite-bio) - [Provention Bio](https://millionrounds.com/company/provention-bio) - [COUR Pharma](https://millionrounds.com/company/cour-pharma) - [Atropos Health](https://millionrounds.com/company/atropos-health) ## Stage not reported 11 - [*DT* Dice Therapeutics](https://millionrounds.com/company/dice-therapeutics) - [MeiraGTx](https://millionrounds.com/company/meiragtx) - [Q32 Bio](https://millionrounds.com/company/q32-bio) - [*GT* Gyroscope Therapeutics](https://millionrounds.com/company/gyroscope-therapeutics) - [SAB Biotherapeutics](https://millionrounds.com/company/sab-biotherapeutics) - [Graviton](https://millionrounds.com/company/graviton) - [Aetion](https://millionrounds.com/company/aetion) - [Inozyme](https://millionrounds.com/company/inozyme) - [Imbria Pharmaceuticals](https://millionrounds.com/company/imbria-pharmaceuticals) - [Veralox Therapeutics](https://millionrounds.com/company/veralox-therapeutics) - [Scribe Therapeutics](https://millionrounds.com/company/scribe-therapeutics) ## Series C and later 9 - [AdvanCell](https://millionrounds.com/company/advancell) - [Electra Therapeutics](https://millionrounds.com/company/electra-therapeutics) - [Glycomine](https://millionrounds.com/company/glycomine) - [Click Therapeutics](https://millionrounds.com/company/click-therapeutics) - [Escient Pharmaceuticals](https://millionrounds.com/company/escient-pharmaceuticals) - [AgomAB Therapeutics](https://millionrounds.com/company/agomab-therapeutics) - [Attovia Therapeutics](https://millionrounds.com/company/attovia-therapeutics) - [Epicrispr Biotechnologies](https://millionrounds.com/company/epicrispr-biotechnologies) - [Adagene](https://millionrounds.com/company/adagene) ## Series A 7 - [Alveus Therapeutics Inc.](https://millionrounds.com/company/alveus-therapeutics-inc) - [*BP* Bionyra Pharma](https://millionrounds.com/company/bionyra-pharma) - [Icosavax](https://millionrounds.com/company/icosavax) - [*MM* Memento Medicines](https://millionrounds.com/company/memento-medicines) - [Areteia Therapeutics](https://millionrounds.com/company/areteia-therapeutics) - [i2o Therapeutics](https://millionrounds.com/company/i2o-therapeutics) - [*N* NeuroVia](https://millionrounds.com/company/neurovia) ## Pre-seed and seed 3 - [Avilar Therapeutics](https://millionrounds.com/company/avilar-therapeutics) - [Eligo Bioscience](https://millionrounds.com/company/eligo-bioscience) - [Curisium](https://millionrounds.com/company/curisium) ## Growth 2 - [*WD* Warp Drive Bio](https://millionrounds.com/company/warp-drive-bio) - [Graviton Bioscience](https://millionrounds.com/company/graviton-bioscience) ## Segment by segment ### Series B 18 startups · $2.4B raised - [**Fulcrum Therapeutics**](https://millionrounds.com/company/fulcrum-therapeutics) Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause. United States $310M - [**Expedition Therapeutics**](https://millionrounds.com/company/expedition-therapeutics) Expedition Therapeutics is a biotechnology company based in San Francisco, founded in 2024. United States $280M - [**T-Therapeutics**](https://millionrounds.com/company/t-therapeutics) T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge. United Kingdom $279M - [**Mirador Therapeutics**](https://millionrounds.com/company/mirador-therapeutics) Mirador Therapeutics is a clinical-stage precision medicine company based in San Diego, California. United States $250M - [**Matchpoint Therapeutics**](https://millionrounds.com/company/matchpoint-therapeutics) Matchpoint Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021. United States $220M - [**Nura Bio**](https://millionrounds.com/company/nura-bio) Nura Bio is a clinical-stage biopharmaceutical company based in South San Francisco, California. United States $142M - [**Vigil Neuroscience**](https://millionrounds.com/company/vigil-neuroscience) Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases. United States $130M - [**NodThera**](https://millionrounds.com/company/nodthera) NodThera is a biotechnology company focused on the discovery and development of new treatments for diseases. United Kingdom $109M ### Stage not reported 11 startups · $1.3B raised - [*DT* **Dice Therapeutics**](https://millionrounds.com/company/dice-therapeutics) Dice Therapeutics is a clinical-stage biopharmaceutical company that makes medicines for chronic autoimmune and inflammatory diseases. United States $345M - [**MeiraGTx**](https://millionrounds.com/company/meiragtx) MeiraGTx is a biotechnology company that focuses on developing gene therapies to treat inherited and acquired genetic disorders. United States $225M - [**Q32 Bio**](https://millionrounds.com/company/q32-bio) Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases. United States $200M - [*GT* **Gyroscope Therapeutics**](https://millionrounds.com/company/gyroscope-therapeutics) Gyroscope Therapeutics is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye. United Kingdom $118M - [**SAB Biotherapeutics**](https://millionrounds.com/company/sab-biotherapeutics) SAB Biotherapeutics is a clinical-stage biopharmaceutical development company. United States $85M - [**Graviton**](https://millionrounds.com/company/graviton) Graviton develops novel therapeutics for the treatment of autoimmune, cancer, certain genetic, fibrotic, and other serious diseases. United States $75M - [**Aetion**](https://millionrounds.com/company/aetion) Aetion provides real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers. United States $74M - [**Inozyme**](https://millionrounds.com/company/inozyme) Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health. United States $60M ### Series C and later 9 startups · $1.4B raised - [**AdvanCell**](https://millionrounds.com/company/advancell) AdvanCell is radiopharmaceutical firm that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment. Australia $438M - [**Electra Therapeutics**](https://millionrounds.com/company/electra-therapeutics) Electra Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California, founded in 2018. United States $183M - [**Glycomine**](https://millionrounds.com/company/glycomine) Glycomine is an early-stage biotech working on replacement therapies for rare diseases. United States $160M - [**Click Therapeutics**](https://millionrounds.com/company/click-therapeutics) Click Therapeutics delivers safe and effective digital treatments to patients in need. United States $149M - [**Escient Pharmaceuticals**](https://millionrounds.com/company/escient-pharmaceuticals) Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs. United States $120M - [**AgomAB Therapeutics**](https://millionrounds.com/company/agomab-therapeutics) AgomAb Therapeutics is a Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues. Belgium $112M - [**Attovia Therapeutics**](https://millionrounds.com/company/attovia-therapeutics) Attovia Therapeutics is a biologics platform specializing in biotherapeutics for immune-mediated diseases. United States $90M - [**Epicrispr Biotechnologies**](https://millionrounds.com/company/epicrispr-biotechnologies) Epicrispr Biotechnologies is a clinical-stage biotechnology company based in South San Francisco, California. United States $90M ### Series A 7 startups · $709M raised - [**Alveus Therapeutics Inc.**](https://millionrounds.com/company/alveus-therapeutics-inc) Alveus Therapeutics Inc is a clinical-stage biotechnology company focused on developing innovative therapies for obesity and metab United States $197M - [*BP* **Bionyra Pharma**](https://millionrounds.com/company/bionyra-pharma) France $165M - [**Icosavax**](https://millionrounds.com/company/icosavax) Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs. United States $119M - [*MM* **Memento Medicines**](https://millionrounds.com/company/memento-medicines) Memento Medicines is a biotech developing bispecific antibody therapies for eye diseases. United Kingdom $93M - [**Areteia Therapeutics**](https://millionrounds.com/company/areteia-therapeutics) Areteia Therapeutics, Inc. United States $75M - [**i2o Therapeutics**](https://millionrounds.com/company/i2o-therapeutics) i2o Therapeutics is a biotechnology company based in Boston, founded in 2019 by researchers from Harvard University. United States $46M - [*N* **NeuroVia**](https://millionrounds.com/company/neurovia) NeuroVia is a biopharmaceutical company. United States $14M ### Pre-seed and seed 3 startups · $26M raised - [**Avilar Therapeutics**](https://millionrounds.com/company/avilar-therapeutics) Avilar Therapeutics is a biopharmaceutical company based in Waltham, Massachusetts, founded in 2020. United States $15M - [**Eligo Bioscience**](https://millionrounds.com/company/eligo-bioscience) Eligobiotics provides a new approach to explore, understand, and control bacterial ecosystems both in human and animals. France $7.2M - [**Curisium**](https://millionrounds.com/company/curisium) Innovative Healthcare Contracting United States $3.5M ### Growth 2 startups · $150M raised - [*WD* **Warp Drive Bio**](https://millionrounds.com/company/warp-drive-bio) Warp Drive Bio develops genomic search engine and customized search queries that reveal hidden natural products based on genomic signature. Brazil $125M - [**Graviton Bioscience**](https://millionrounds.com/company/graviton-bioscience) Biotechnology, clinical stage, CNC, autoimmune, fibrotic indications United States $25M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Sanofi as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Portfolio map **Sanofi portfolio map** 70 startups · $9.8B](https://millionrounds.com/portfolio-maps/sanofi-portfolio-map)[Co-investors **Who invests with Sanofi** 56 co-investors](https://millionrounds.com/portfolio-maps/sanofi-co-investors)[Investments abroad **Sanofi's investments in the United States** 55 startups · $7.0B](https://millionrounds.com/portfolio-maps/sanofi-investments-united-states)[Sector portfolio **Y Combinator's AI portfolio** 1,143 startups · $44B](https://millionrounds.com/portfolio-maps/y-combinator-ai-portfolio)[Sector portfolio **Y Combinator's Fintech portfolio** 338 startups · $24B](https://millionrounds.com/portfolio-maps/y-combinator-fintech-portfolio)[Sector portfolio **Techstars' AI portfolio** 336 startups · $4.9B](https://millionrounds.com/portfolio-maps/techstars-ai-portfolio) ## Raising from investors like Sanofi? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)